The Relationship Between the Tumor Cell Expression of Hypoxic Markers
and Survival in Patients With ER-positive Invasive Ductal Breast
Cancer |
| |
Authors: | Suad A.K. Shamis Jean Quinn Elizabeth E.A. Mallon Joanne Edwards Donald C. McMillan |
| |
Affiliation: | Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow, United Kingdom;Unit of Molecular Pathology, Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom;Department of Pathology, Queen Elizabeth University Hospital, Glasgow, United Kingdom |
| |
Abstract: | The prognostic significance of hypoxia markers, hypoxia-inducible factor-1α (HIF-1α), hypoxia-inducible factor-2α (HIF-2α), and carbonic anhydrase IX (CAIX), was investigated in estrogen receptor (ER)-positive breast cancer patients. Immunohistochemistry determined the expression of makers in two independent ductal ER-positive cohorts (Training set, n=373 and Validation set, n=285) and was related to clinicopathological parameters and disease-free survival (DFS). In the training cohort, nuclear HIF-1α (1) was independently associated with poorer DFS in luminal A tumors [hazard ratio (HR) = 0.53 95% confidence interval (CI): 0.30–0.94, p=0.030]. In the validation cohort, both HIF-1α (1) and CAIX were independently associated with decreased DFS in the entire cohort (HR = 1.85 95% CI: 1.10–3.11, p=0.019; HR = 1.74 95% CI: 1.08–2.82, p=0.023), in luminal A disease (HR = 1.98 95% CI: 1.02–3.83, p=0.042), and in luminal B disease (HR = 2.75 95% CI: 1.66–4.55, p<0.001), respectively. Taken together, elevated cytoplasmic HIF-1α (1) expression was an independent prognostic factor in luminal A disease, whereas CAIX was an independent prognostic factor in luminal B disease. Further work in large tissue cohorts is required. |
| |
Keywords: | breast cancer, carbonic anhydrase IX, hypoxia-inducible factor-1α , hypoxia-inducible factor-2α , survival, tumor hypoxia |
|
|